Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $730043.4.

  • AC Immune's Other Non-Current Assets rose 5241.12% to $730043.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $730043.4, marking a year-over-year increase of 5241.12%. This contributed to the annual value of $473731.6 for FY2024, which is 9988.36% down from last year.
  • As of Q3 2025, AC Immune's Other Non-Current Assets stood at $730043.4, which was up 5241.12% from $705408.0 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Other Non-Current Assets ranged from a high of $407.0 million in Q4 2023 and a low of $373799.8 during Q3 2022
  • Over the past 5 years, AC Immune's median Other Non-Current Assets value was $475458.2 (recorded in 2024), while the average stood at $103.7 million.
  • In the last 5 years, AC Immune's Other Non-Current Assets skyrocketed by 12607730.92% in 2021 and then crashed by 9990.58% in 2022.
  • AC Immune's Other Non-Current Assets (Quarter) stood at $393.7 million in 2021, then tumbled by 99.9% to $374725.9 in 2022, then skyrocketed by 108506.06% to $407.0 million in 2023, then plummeted by 99.88% to $473731.6 in 2024, then soared by 54.1% to $730043.4 in 2025.
  • Its last three reported values are $730043.4 in Q3 2025, $705408.0 for Q2 2025, and $650666.6 during Q1 2025.